A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled studies, were recently authorized in most countries for adults with chronic immune thrombocytopenia. So far, no data are available about the po...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Khellaf, Mehdi, Viallard, Jean-François, Hamidou, Mohamed, Cheze, Stéphane, Roudot-Thoraval, Françoise, Lefrere, François, Fain, Olivier, Audia, Sylvain, Abgrall, Jean-François, Michot, Jean-Marie, Dauriac, Charles, Lefort, Sophie, Gyan, Emmanuel, Niault, Mathilde, Durand, Jean-Marc, Languille, Laetitia, Boutboul, David, Bierling, Philippe, Michel, Marc, Godeau, Bertrand
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2013
Témata:
Original Articles and Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669443/
https://ncbi.nlm.nih.gov/pubmed/23445876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.074633
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky